Literature DB >> 20888880

TLR4 upregulation underpins airway neutrophilia in smokers with chronic obstructive pulmonary disease and acute respiratory failure.

Elisabetta Pace1, Antonino Giarratano, Maria Ferraro, Andreina Bruno, Liboria Siena, Salvatore Mangione, Malcolm Johnson, Mark Gjomarkaj.   

Abstract

Activation of Toll-like receptors (TLR) seems to be involved in the pathogenesis of chronic obstructive pulmonary disease (COPD). Upon TLR activation the release of defensins, including human beta defensin 2 (HBD-2), may occur. In this study, we explored the innate responses in patients with respiratory failure, with and without COPD, requiring intubation and mechanical ventilation. Mini-bronchoalveolar lavage (mini-BAL) samples were collected from nonsmoker subjects without COPD (n = 10), smokers without COPD (n = 6), and smokers with COPD (n = 15). TLR4, TLR2, and HBD-2 expression was evaluated by immunocytochemistry; interleukin (IL)-8, IP-10, and HBD-2 concentrations were evaluated by enzyme-linked immunosorbent assay; chemotactic activity toward neutrophils and lymphocytes; and cell apoptosis was evaluated by terminal deoxynucleotidyl transferase dUTP nick end labeling [TUNEL] and by flow cytometry with anti-TLR4 and with HBD-2 depleted and not depleted mini-BAL). COPD mini-BAL showed increased neutrophil numbers, reduced neutrophil apoptosis, increased TLR4 and HBD-2 expression, increased neutrophil chemotactic activity, reduced IP-10 concentrations, and reduced lymphocyte chemotactic activity compared with those in nonsmoker subjects without COPD. In the smokers without COPD the mini-BAL showed reduced TLR4 and HBD-2 expression, higher IP-10 concentrations, and higher chemotactic activity than in patients with COPD. The blocking of TLR4 activation and HBD-2 depletion increased neutrophil apoptosis. No differences were observed for TLR2 expression and IL-8 concentrations. This study strengthens the contribution of TLR4 to promoting airway neutrophilia in COPD.
Copyright © 2011 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20888880     DOI: 10.1016/j.humimm.2010.09.009

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  24 in total

1.  Inhaled LPS challenges in smokers: a study of pulmonary and systemic effects.

Authors:  Raminder Aul; Jane Armstrong; Annelyse Duvoix; David Lomas; Brian Hayes; Bruce E Miller; Chris Jagger; Dave Singh
Journal:  Br J Clin Pharmacol       Date:  2012-12       Impact factor: 4.335

Review 2.  Toll like receptors in diseases of the lung.

Authors:  Melissa A Kovach; Theodore J Standiford
Journal:  Int Immunopharmacol       Date:  2011-05-30       Impact factor: 4.932

3.  MD2 expression is reduced in large airways of smokers and COPD smokers.

Authors:  Elisabetta Pace; Maria Ferraro; Giuseppina Chiappara; Patrizio Vitulo; Loredana Pipitone; Serena Di Vincenzo; Mark Gjomarkaj
Journal:  Mol Cell Biochem       Date:  2015-06-12       Impact factor: 3.396

4.  Functional polymorphisms in toll-like receptor 4 are associated with worse outcome in acute ischemic stroke patients.

Authors:  Jonathan R Weinstein; Juliane Schulze; Richard V Lee; Hunter Phillips; Dannielle Zierath; Patricia Tanzi; Dean Shibata; Kevin C Cain; Kyra J Becker
Journal:  Neuroreport       Date:  2014-05-28       Impact factor: 1.837

Review 5.  DAMPs activating innate and adaptive immune responses in COPD.

Authors:  S D Pouwels; I H Heijink; N H T ten Hacken; P Vandenabeele; D V Krysko; M C Nawijn; A J M van Oosterhout
Journal:  Mucosal Immunol       Date:  2013-10-23       Impact factor: 7.313

6.  In vitro cytotoxicity and mutagenicity of mainstream waterpipe smoke and its functional consequences on alveolar type II derived cells.

Authors:  Mayyasa Rammah; Farah Dandachi; Rola Salman; Alan Shihadeh; Marwan El-Sabban
Journal:  Toxicol Lett       Date:  2012-04-10       Impact factor: 4.372

7.  Cigarette smoke increases BLT2 receptor functions in bronchial epithelial cells: in vitro and ex vivo evidence.

Authors:  Elisabetta Pace; Maria Ferraro; Serena Di Vincenzo; Andreina Bruno; Antonino Giarratano; Valeria Scafidi; Luana Lipari; Denise Valentina Di Benedetto; Serafina Sciarrino; Mark Gjomarkaj
Journal:  Immunology       Date:  2013-06       Impact factor: 7.397

8.  Resolvin D2 decreases TLR4 expression to mediate resolution in human monocytes.

Authors:  Amanda Croasdell; Patricia J Sime; Richard P Phipps
Journal:  FASEB J       Date:  2016-06-02       Impact factor: 5.191

9.  Cigarette smoke increases TLR4 and TLR9 expression and induces cytokine production from CD8(+) T cells in chronic obstructive pulmonary disease.

Authors:  Jessica Nadigel; David Préfontaine; Carolyn J Baglole; François Maltais; Jean Bourbeau; David H Eidelman; Qutayba Hamid
Journal:  Respir Res       Date:  2011-11-09

10.  Toll-like receptor (TLR2 and TLR4) polymorphisms and chronic obstructive pulmonary disease.

Authors:  Simona E Budulac; H Marike Boezen; Pieter S Hiemstra; Therese S Lapperre; Judith M Vonk; Wim Timens; Dirkje S Postma
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.